학술논문
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG
Document Type
Article
Author
Loo, S.; Roberts, A.W.; Tiong, I.S.; Bajel, A.; Seymour, J.F.; Wei, A.H.; Anstee, N.S.; Kennedy, G.A.; Morris, K.; He, S.; Fong, C.Y.; Schwarer, A.P.; Ting, S.B.; Enjeti, A.K.; Yuen, S.; D'Rozario, J.; Latimer, M.; Marlton, P.; Bilmon, I.A.; Taper, J.; Cull, G.; Tiley, C.; Verner, E.; Hahn, U.; Hiwase, D.K.; Iland, H.J.; Murphy, N.; Ramanathan, S.; Reynolds, J.; Ong, D.M.; Wall, M.; Murray, M.; Rawling, T.; Leadbetter, J.; Rowley, L.; Levis, M.J.
Source
In: Blood . (Blood, 7 December 2023, 142(23):1960-1971)
Subject
Language
English
ISSN
15280020
00064971
00064971